|Last Price$74.55||Day Change (%)-0.20%|
|Open Price$74.74||Day Change ($)-0.15|
|Day Range74.08–74.74||52-Week Range62.80–77.31|
As of Mon 09/15/2014 03:39 PM EST | USD
FDA Approves Baxter ’s HYQVIA for Treatment of Adults with Primary Immunodeficiency
Research and Markets: Pharmacy Automation Systems Market to 2019: Medication Dispensing Systems, Packaging and Labeling Systems & Table-top Counters Analysis
Research and Markets: Global Wound Care (Wound Closure, Anti infective) Market - Forecast to 2019
Research and Markets: Asia-Pacific Infusion Therapy Device Market - Executive Summary Report 2014
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Ipsen: 2014 Half-Year Results and 2014 Objectives
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
USIBC Concludes Successful Medical Device Mission to India
The diversified health-care firm remains remarkably profitable in tough industries.